WILMINGTON, Del. - Bankrupt Savient Pharmaceuticals Inc. on Dec. 18 moved in the U.S. Bankruptcy Court for the District of Delaware for approval of a global settlement agreement that would allow its landlord to assert a claim against the bankruptcy estate for $2,062,000 in exchange for an agreement to terminate the lease for the company's headquarters (In Re: Savient Pharmaceuticals Inc., No. 13-12680, Chapter 11, D. Del. Bkcy.).